Andrew Hemphill Selected Research

Alveolar echinococcosis

10/2021	Maca against Echinococcosis?-A Reverse Approach from Patient to In Vitro Testing.
12/2020	Short communication: Efficacy of albendazole in Echinococcus multilocularis-infected mice depends on the functional immunity of the host.
1/2020	Regulation of hepatic microRNAs in response to early stage Echinococcus multilocularis egg infection in C57BL/6 mice.
1/2020	Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis.
6/2019	The importance of being parasiticidal… an update on drug development for the treatment of alveolar echinococcosis.
12/2018	Repurposing of an old drug: In vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularis.
5/2018	Evaluation of kinase-inhibitors nilotinib and everolimus against alveolar echinococcosis in vitro and in a mouse model.
10/2015	Susceptibility versus resistance in alveolar echinococcosis (larval infection with Echinococcus multilocularis).
5/2015	Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4+ CD25+ Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice.
1/2015	Prevention and Immunotherapy of Secondary Murine Alveolar Echinococcosis Employing Recombinant EmP29 Antigen.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew Hemphill Research Topics

Disease

51	Infections 01/2022 - 02/2003
16	Alveolar echinococcosis 10/2021 - 04/2004
9	Neoplasms (Cancer) 11/2021 - 10/2008
6	Toxoplasmosis 12/2021 - 01/2017
6	Parasitic Diseases (Parasitic Disease) 10/2021 - 05/2015
6	Malaria 03/2020 - 04/2005
5	Echinococcosis (Hydatid Cysts) 12/2021 - 11/2006
4	Giardiasis 01/2022 - 12/2007
4	Coccidiosis 10/2021 - 10/2011
4	Cysts 10/2015 - 06/2002
3	Theileriasis 02/2016 - 04/2015
2	Cryptosporidiosis 01/2021 - 10/2017
2	Body Weight (Weight, Body) 01/2019 - 02/2011
2	Colonic Neoplasms (Colon Cancer) 10/2008 - 01/2006
1	Neurocysticercosis 12/2021
1	Bronchopneumonia 06/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Adenocarcinoma of Lung 12/2020
1	Stillbirth 09/2020
1	Reinfection 01/2020
1	Rare Diseases (Rare Disease) 06/2019
1	Strongyloidiasis 01/2019
1	Diarrhea 01/2019
1	Fever (Fevers) 01/2018
1	Babesiosis (Piroplasmosis) 01/2018
1	Cardiotoxicity 10/2017
1	Congenital Toxoplasmosis 01/2017
1	Eye Infections 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 03/2016

Drug/Important Bio-Agent (IBA)

16	VaccinesIBA 01/2022 - 06/2005
16	Pharmaceutical PreparationsIBA 01/2022 - 05/2006
14	Proteins (Proteins, Gene)FDA Link 11/2021 - 06/2002
13	AntigensIBA 12/2021 - 01/2004
10	Phosphotransferases (Kinase)IBA 01/2022 - 01/2017
8	nitazoxanide (NTZ)FDA Link 06/2019 - 04/2004
6	BenzimidazolesIBA 12/2021 - 10/2011
6	Albendazole (Albenza)FDA Link 12/2020 - 04/2004
6	buparvaquoneIBA 06/2019 - 04/2015
4	Mefloquine (Lariam)FDA LinkGeneric 01/2020 - 02/2011
4	RutheniumIBA 10/2019 - 01/2017
3	calcium-dependent protein kinaseIBA 12/2021 - 01/2017
3	Antimalarials (Antimalarial Agents)IBA 03/2020 - 02/2016
3	5- chloro- 2- hydroxy- N- (3- (trifluoromethyl)phenyl)benzamideIBA 06/2019 - 03/2016
3	IsoflavonesIBA 06/2019 - 11/2006
3	AntibodiesIBA 01/2019 - 10/2017
3	Metronidazole (Metric)FDA LinkGeneric 01/2018 - 01/2006
3	NaphthoquinonesIBA 01/2017 - 04/2015
3	Mebendazole (Anti-Worm)FDA Link 04/2014 - 08/2013
3	CytokinesIBA 09/2011 - 04/2009
2	QuinolonesIBA 12/2021 - 10/2021
2	DecoquinateIBA 10/2021 - 09/2018
2	beta-Galactosidase (Lactaid)IBA 03/2020 - 01/2019
2	Bortezomib (Velcade)FDA Link 06/2019 - 12/2014
2	artemisinin (artemisinine)IBA 06/2019 - 12/2017
2	DB1127IBA 06/2019 - 10/2011
2	EpitopesIBA 10/2018 - 10/2012
2	Peptides (Polypeptides)IBA 10/2018 - 04/2005
2	Immunoglobulin G (IgG)IBA 01/2018 - 10/2007
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 03/2015
2	SaponinsIBA 01/2015 - 03/2013
2	Surface Antigens (Surface Antigen)IBA 04/2005 - 01/2004
1	pyridazineIBA 01/2022
1	Praziquantel (Biltricide)FDA Link 12/2021
1	Dihydrotachysterol (AT 10)IBA 10/2021
1	Coloring Agents (Dyes)IBA 06/2021
1	Cisplatin (Platino)FDA LinkGeneric 12/2020
1	Pyrimethamine (Daraprim)FDA Link 12/2020
1	Fertility AgentsIBA 09/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Clarithromycin (Biaxin)FDA LinkGeneric 06/2019
1	Vinorelbine (Navelbine)FDA LinkGeneric 06/2019
1	2-MethoxyestradiolIBA 06/2019
1	Amphotericin B (Amphotericin)FDA LinkGeneric 06/2019
1	Methotrexate (Mexate)FDA LinkGeneric 06/2019
1	Vincristine (Oncovin)FDA LinkGeneric 06/2019
1	Itraconazole (Sporanox)FDA LinkGeneric 06/2019
1	Taxoids (Taxanes)IBA 06/2019
1	BKI 1369IBA 01/2019
1	Interferon-gamma (Interferon, gamma)IBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 01/2019
1	toltrazurilIBA 01/2019
1	diclazurilIBA 09/2018
1	nilotinib FDA Link 05/2018
1	Everolimus FDA Link 05/2018
1	Retinaldehyde (Retinal)IBA 04/2018
1	ProdrugsIBA 01/2018
1	BKI-1553IBA 01/2018
1	Nitro CompoundsIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	PeroxidesIBA 12/2017
1	Drinking WaterIBA 09/2017
1	Protein Kinases (Protein Kinase)IBA 09/2017
1	Penicillins (Penicillin)FDA Link 01/2017
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2017
1	salicylanilideIBA 03/2016

Therapy/Procedure

12	Therapeutics 01/2021 - 01/2007
5	Drug Therapy (Chemotherapy) 01/2022 - 04/2004
2	Immunotherapy 05/2015 - 01/2015
2	Intraperitoneal Injections 12/2014 - 10/2011